Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease-Reference-Cited by-同舟云学术

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease

Published:2014-07-29 Issue:9 Volume:12 Page:1494-1502
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Gaillard S.¹²³,Dupuis-Girod S.⁴⁵⁶⁷,Boutitie F.²³⁸⁹,Rivière S.¹⁰,Morinière S.¹¹,Hatron P.-Y.¹²,Manfredi G.¹³,Kaminsky P.¹⁴,Capitaine A.-L.¹⁵,Roy P.²³⁸⁹,Gueyffier F.¹²³,Plauchu H.⁴⁵⁶⁷,

Affiliation:

1. INSERM, CIC 1407 Lyon; Hospices Civils de Lyon; Service de Pharmacologie Clinique Lyon; Université de Lyon; Lyon France

2. Université Lyon 1; Villeurbanne France

3. CNRS, UMR5558; Laboratoire de Biométrie et Biologie Evolutive; Equipe Biotatistique-Santé; Villeurbanne France

4. Hospices Civils de Lyon; Hôpital Louis Pradel, Service de Génétique et Centre de Référence National Maladie de Rendu-Osler; Service ORL; Bron France

5. Hôpital Edouard Herriot; Service ORL; Lyon France

6. Hôpital de la Croix Rousse; Service ORL; Lyon France

7. Université Lyon 1; Lyon France

8. Hospices Civils de Lyon; Service de Biostatistique; Lyon France

9. Université de Lyon; Lyon France

10. Centre Hospitalier et Universitaire de Montpellier; Service de Médecine Interne; Montpellier France

11. Centre Hospitalier et Universitaire de Tours; Hôpital Bretonneau, Service ORL; Service de Pneumologie; Tours France

12. Centre Hospitalier Régional et Universitaire de Lille; Hôpital Huriez, Service de Médecine Interne; Hôpital Jeanne de Flandre; Service de Génétique; Lille France

13. Gastroenterology Department; HHT Centre for the National Network of Rare Diseases; Maggiore Hospital; Crema Italy

14. Centre Hospitalier et Universitaire de Nancy; Hôpital Brabois, Service de Médecine Interne; Hôpital Central; Service ORL; Nancy France

15. Centre Hospitalier et Universitaire de Poitiers; Hôpital Jean Bernard, Service ORL; Service de Génétique; Poitiers France

Funder

Hospices Civils de Lyon (France)

French Ministry of Health

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12654/fullpdf

Reference22 articles.

1. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence;Bideau;Popul,1989

2. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome);Shovlin;Am J Med Genet,2000

4. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1;McAllister;Nat Genet,1994

5. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2;Johnson;Nat Genet,1996

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary hemorrhagic telangiectasia (Osler’s disease): systemic, interdisciplinary, relatively common—and often missed;Deutsches Ärzteblatt international;2024-09-06

2. How I treat bleeding in hereditary hemorrhagic telangiectasia;Blood;2024-08-29

3. Comparative Study of Topical Application of Injection Tranexamic Acid and Anterior Nasal Packing in the Management of Epistaxis;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-04-05

4. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management—Exploring the otolaryngologist's integral role;Auris Nasus Larynx;2024-04

5. Rare bleeding disorders: Advances in management;Haemophilia;2024-03-18